Abstract Since passage of the Affordable Care Act (ACA) in 2010, US stakeholders are increasingly being held accountable for the value of healthcare services and drugs administered to patients. Pharmacoeconomic analyses offer one method of demonstrating a product’s value, yet there is a lack of resources specific to US drug costs relevant to each stakeholder. The aim of this study was to review current US drug costs (post-ACA). A literature review aimed at finding evidence on outpatient prescription drug costs was performed using the following sources: PubMed, governmental agencies, news websites, the Academy of Managed Care Pharmacy (AMCP) website, and Google Scholar. Articles were limited to those published in the years “2010–2016” and the “English” language, and those that described drug acquisition costs, reimbursement costs, and rebates or discounting for Medicare, Medicaid, and commercial payors. The Drug Cost Focus Group (DCFG) was convened to supplement the literature review; the DCFG provided their expertise on US drug costs and emerging issues affecting drug costs. ACA legislation increased drug rebates for manufacturers participating in the Medicaid Drug Rebate Program. Acquisition costs commonly referred to in the literature include the wholesale acquisition cost and average manufacture price. Drugs reimbursed by Medicaid are currently based on the actual acquisition cost and ACA-Federal Upper Limit. Evidence suggests that reimbursement methods in the public market are varied. Current gaps in the literature regarding commercial insurers’ drug costs (post-ACA) present barriers to the application of relevant drug costs to pharmacoeconomic analyses.
stakeholders        0.995885571844814^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Stakeholder_(corporate)

Medicaid                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Medicaid              

literature                    0.9999998124874485^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Literature            

English                       0.9896589384623288^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/English_language      

US                            0.9914096790397874^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/United_States_dollar  

Focus                         0.7641863893153487^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ford_Focus            

drug                          0.999999350207174^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Pharmaceutical_drug   

US                            0.9914096790397874^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/United_States_dollar  

rebates                       0.9999976141228939^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Rebate_(marketing)    

drug                          0.999999350207174^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Pharmaceutical_drug   

legislation                   0.9999999999995453^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Legislation           

healthcare                    0.9999999999988631^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Health_care           

stakeholder                   0.9948460518433758^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stakeholder_(corporate)

ACA                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Patient_Protection_and_Affordable_Care_Act

Medicaid Drug Rebate Program  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Medicaid_Drug_Rebate_Program

language                      0.6297863016850802^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Language              

drugs                         0.9999992280257426^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

drug                          0.999999350207174^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Pharmaceutical_drug   

Medicare                      0.6996914537386699^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Centers_for_Medicare_and_Medicaid_Services

Pharmacy                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pharmacy              

Affordable Care Act           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Patient_Protection_and_Affordable_Care_Act

prescription drug             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prescription_drug     

public market                 0.9993996357730283^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stock_market          

drug                          0.999999350207174^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Pharmaceutical_drug   

literature review             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Literature_review     

outpatient                    0.9999999871936326^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Patient               

discounting                   0.9995517420780264^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Discounting           

drug                          0.999999350207174^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Pharmaceutical_drug   

literature review             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Literature_review     

Managed Care                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Managed_care          

rebates                       0.9999976141228939^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Rebate_(marketing)    

wholesale                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Wholesale             

drug                          0.999999350207174^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Pharmaceutical_drug   

US                            0.9914096790397874^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/United_States_dollar  

literature                    0.9999998124874485^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Literature            

drug                          0.999999350207174^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Pharmaceutical_drug   

Medicaid                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Medicaid              

Google Scholar                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Google_Scholar        

drug                          0.999999350207174^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Pharmaceutical_drug   

PubMed                        0.9999999999979536^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/PubMed                

US                            0.9914096790397874^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/United_States_dollar  

ACA                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Patient_Protection_and_Affordable_Care_Act

